Wang-Long Chuang

33PUBLICATIONS

112CO-AUTHORS

Metabolic medicineOccupational epidemiologyPredictive and prognostic markersPharmacogenomicsCardiology (incl. cardiovascular diseases)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (33)

Sort by Publication Date:

|Jul 14, 2026

Cardiometabolic Biomarkers for Disease Severity Prediction in Metabolic Dysfunction-Associated Steatotic Liver Disease.

|Jun 10, 2026

Letter: Reconsidering Tenofovir Disoproxil Fumarate Use in Light of Emerging Safety Evidence-Authors' Reply.

|May 25, 2026

Editorial: Liver and Non-Liver Outcomes Between Different Subtypes of Steatotic Liver Disease.

|May 21, 2026

Safety, Tolerability, and Pharmacodynamics of GS-4224 in Healthy Participants and Participants With Chronic Hepatitis B.

|Apr 23, 2026

Impact of Cardiometabolic Risk Factors and Steatotic Liver Disease on Liver-Related Outcomes in Patients With Chronic Hepatitis C After Curative Antiviral Therapy.

|Feb 22, 2026

Long-Term Mortality Following Hepatitis C Cure in a Real-World Multinational Cohort.

Fanpu Ji, Sally Tran, Hidenori Toyoda

Pageof 6

Frequent Collaborators

23 joint publications

Ming-Lung Yu

20 joint publications

Jee-Fu Huang

19 joint publications

Chia-Yen Dai

17 joint publications

Chung-Feng Huang

14 joint publications

Ming-Lun Yeh

11 joint publications

Pei-Chien Tsai

8 joint publications

Po-Cheng Liang

6 joint publications

Tyng-Yuang Jang

5 joint publications

Shu-Chi Wang